https://adisinsight.springer.com/trials/700392532?error=cookies_not_supported&code=4bcce97c-b775-4ef5-9488-0764d2abe2c4
A Clinical Study of CHT102, a Universal Chimeric Antigen Receptor T-Cell Immunotherapy(U CAR-T) for...
To evaluate the safety and efficacy of MSLN-targeting Universal Chimeric Antigen Receptor T-Cell Immunotherapy(U CAR-T) in the treatment of MSLN-positive